Skip to main content

Advertisement

Table 3 The relationship between response intensity of HPV E1-specific T cell response in peripheral blood and the clinical features in patients with cervical squamous cell carcinoma

From: Human papilloma virus E1-specific T cell immune response is associated with the prognosis of cervical cancer patients with squamous cell carcinoma

Factor N Mean magnitude (SFC/106) Z P-value
Age
(year)
≤54 32 20.06 −0.598 0.550
> 54 34 28.05
Family history of cancer No 59 24.74 −0.570 0.568
Yes 7 23.4
History of miscarriage No 30 24.88 −0.570 0.569
Yes 36 24.32
Tumor size
(cm)
≤5 43 23.4 −0.662 0.508
> 5 23 26.64
Tumor type Cauliflower 25 24.77 −0.115 0.909
Nodular 29 24.65
Hollow 7 24.6
Others 5 23.5
Histologic grade Well 2 0 −1.826 0.068
Moderate 45 21.31
Poor 13 39.28
Papillary 6 21.67
FIGO stage IIB 34 27.45 −2.077 0.038
IIIA-IIIB 32 21.53
SCC-Ag Normal 12 23 −0.419 0.675
Anormal 54 25.03
CEA Normal 42 22.56 −1.239 0.215
Anormal 24 29.08
TSGF Normal 46 30.72 −1.958 0.050
Anormal 20 13.57
Pelvic
lymph nodes
No 37 25.58 −2.017 0.044
Yes 29 22.93
  1. N number of patients, Mean magnitude of T cell response of the population, FIGO International Federation of Gynecology and Obstetrics, SCC-Ag Squamous cell carcinoma antigen, CEA carcinoembryonic antigen, TSGF Tumor specific growth factor